Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C

Journal of Viral Hepatitis

Volumn 20, Issue 8, 2013, Pages 517-523

  Zampino, R ^a   Coppola, N ^a   Cirillo, G ^a   Boemio, A ^a   Pisaturo, M ^a   Marrone, A ^a   Macera, M ^a   Sagnelli, E ^a   Perrone, L ^a   Adinolfi, L E ^a   Miraglia Del Giudice, E ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

abdominal fat; APOC3; chronic hepatitis C; liver steatosis; PNPLA3

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN C3; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3; PHOSPHOLIPASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DISEASE SEVERITY; DRUG DEPENDENCE; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE FREQUENCY; GENOTYPE; GLUCOSE BLOOD LEVEL; HEPATITIS C; HEREDITY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; APOC3; CHRONIC HEPATITIS C; LIVER STEATOSIS; PNPLA3;

ABDOMINAL FAT; ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN C-III; FATTY LIVER; FEMALE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; ITALY; LIPASE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTANT PROTEINS; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84879798869     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12053     Document Type: Article

References (34)

1. Angulo P,. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
2. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G,. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33: 1358-1364.
3. Jenkins CM, Mancuso DJ, Yan W, Sims HF, Gibson B, Gross RW,. Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 2004; 279: 48968-48975.
4. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL,. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 1990; 17: 249.
5. van Dijk KW, Rensen PC, Voshol PJ, Havekes LM,. The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism? Curr Opin Lipidol 2004; 15: 239-246.
6. Pollin TI, Damcott CM, Shen H, et al,. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 2008; 12: 322.
7. He S, McPhaul C, Li JZ, et al,. A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis. J Biol Chem 2010; 285: 6706-6715.
8. Romeo S, Kozlitina J, Xing C, et al,. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40: 1461-1465.
9. Speliotes EK, Butler JL, Palmer CD, Voight BF,. GIANT Consortium; MIGen Consortium; NASH CRN, Hirschhorn JN. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 2010; 52: 904-912.
10. Lee HY, Birkenfeld AL, Jornayvaz FR, et al,. Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance. Hepatology 2011; 54: 1650-1660.
11. Petersen KF, Dufour S, Hariri A, et al,. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 2010; 25: 362.
12. Kozlitina J, Boerwinkle E, Cohen JC, Hobbs HH,. Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance. Hepatology 2011; 53: 467-474.
13. Valenti L, Nobili V, Al-Serri A, et al,. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver. J Hepatol 2011; 55: 1409-1414.
14. Valenti L, Rumi MG, Galmozzi E, et al,. Patatin-Like Phospholipase Domain-Containing 3 I148M Polymorphism, Steatosis, and Liver Damage in Chronic Hepatitis C. Hepatology 2011; 53: 791-799.
15. Trepo E, Pradat P, Potthoff A, et al,. Impact of Patatin-Like Phospholipase-3 (rs738409 C>G) Polymorphism on Fibrosis Progression and Steatosis in Chronic Hepatitis C. Hepatology 2011; 54: 60-69.
16. Müller T, Buch S, Berg T, Hampe J, Stickel F,. Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C. J Hepatol 2011; 55: 732-733.
17. Cai T, Dufour JF, Tilman BM, et al,. Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis. J Hepatol 2011; 55: 529-535.
18. Corradini SG, Burza MA, Molinaro A, Romeo S,. Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma. Hepatology 2011; 53: 1776.
19. Zampino R, Marrone A, Merola A, et al,. Long-term outcome of hepatitis B and hepatitis C virus co-infection and single HBV infection acquired in youth. J Med Virol 2009; 81: 2012-2020.
20. Ishak K, Baptista A, Bianchi L, et al,. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
21. Ratge D, Scheiblhuber B, Nitsche M, Knabbe C,. High-speed detection of blood-borne hepatitis C virus RNA by single-tube real-time fluorescence reverse-transcription PCR with LightCycler. Clin Chem. 2000; 46: 1987-1989.
22. Sagnelli E, Coppola N, Pisaturo M, et al,. HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV. Hepatology 2009; 49: 1090-1097.
23. Miraglia del Giudice E, Grandone A, Cirillo G, et al,. The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat. PLoS ONE 2011; 6 (11): e27933.
24. Paré G, Cook NR, Ridker PM, Chasman DI,. On the use of variance per genotype as a tool to identify quantitative trait interaction effects: a report from the Women's Genome Health Study. PLoS Genet 2010; 6: e1000981.
25. Romeo S, Sentinelli F, Dash S, et al,. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Int J Obes 2010; 34: 190-194.
26. Romeo S, Sentinelli F, Cambuli VM, et al,. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J Hepatol 2010; 53: 335-338.
27. Valenti L, Aghemo A, Stättermayer F, et al,. Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin. Aliment Pharmacol Ther 2012; 35 (12): 1434-1442.
28. Coban N, Onat A, Guclu-Geyik F, et al,. Gender- and obesity-specific effect of apolipoprotein C3 gene (APOC3) -482C>T polymorphism on triglyceride concentration in Turkish adults. Clin Chem Lab Med 2011; 2: 285-292.
29. Lin J, Fang DZ, Du J, et al,. Elevated levels of triglyceride and triglyceride-rich lipoprotein induced by a high-carbohydrate diet is associated with polymorphisms of APOA5-1131T>C and APOC3-482C>T in Chinese healthy young adults. Ann Nutr Metab 2011; 58 (2): 150-157.
30. Delgado-Lista J, Perez-Jimenez F, Ruano J, et al,. Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men. J Lipid Res 2010; 51 (1): 63-73.
31. Després JP, Lemieux I,. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881-887.
32. Hsieh SD, Yoshinaga H, Muto T,. Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes Relat Metab Disord 2003; 27: 610-616.
33. Stickel F, Buch S, Lau K, et al,. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians. Hepatology 2011; 53: 86-95.
34. Nischalke HD, Berger C, Luda C, et al,. The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis. PLoS ONE 2011; 6 (11): e27087.